MarCom Europe: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on MarCom Europe.

Press releases published on April 22, 2026

Apr. 22, 2026

2020 VISION TALK SHOW OFFICIALLY REBOOTS IN LAS VEGAS

Indeterminate EIN Presswire

Apr. 22, 2026

Hazen Law Group Announces Reappointment of Sarah E. Straub as Vice Chair of Pennsylvania Bar Association Agricultural Law Committee

Indeterminate LFN-PREMIUM-Network – Law Firm Newswire

Apr. 22, 2026

Dark Steampunk Novel 'The Hollow Clock' Exposes the Cost of Progress in a City Built on Stolen Lives

Indeterminate EIN Presswire

Apr. 22, 2026

African Bush Camps Appoints Maija de Rijk-Uys as Group Managing Director

Indeterminate EIN Presswire

Apr. 22, 2026

Xotiv Introduces GenAI Clinical Workflow Automation With Governance Controls

Indeterminate EIN Presswire

Apr. 22, 2026

Tal appoints Brandnation to lead UK launch of footcare range

Indeterminate EIN Presswire

Apr. 22, 2026

New Best Practice Guide for Ensuring Accessible Math in PDF files

Indeterminate EIN Presswire

Apr. 22, 2026

WEMA Global Announces Winners of the WEMA Circle Awards 2025 in Naples

Indeterminate EIN Presswire

Apr. 22, 2026

ZenFlip and Fido Join Forces to Power Intelligent Publishing

Indeterminate EIN Presswire

Apr. 22, 2026

Univest Securities, LLC Ranked 5th in the Q1 2026 U.S. PIPE and Private Placement Markets Investment Banking League Table by Number of Transactions

Indeterminate GlobeNewswire

Apr. 22, 2026

The 2026 NAB Show Wraps with Proof the Future of Media and Entertainment is Expanding Beyond Broadcasting

Indeterminate GlobeNewswire

Apr. 22, 2026

Clearfield Sets Fiscal Second Quarter 2026 Earnings Call for Wednesday, May 6, 2026

Indeterminate GlobeNewswire

Apr. 22, 2026

Press Release: Sanofi and Regeneron’s Dupixent approved in the US as the first biologic medicine for young children with uncontrolled chronic spontaneous urticaria

Indeterminate GlobeNewswire

Apr. 22, 2026

Communiqué de presse : Dupixent, développé par Sanofi et Regeneron, a été approuvé aux États-Unis comme étant le premier médicament biologique pour les jeunes enfants atteints d’urticaire chronique spontanée non contrôlée

Indeterminate GlobeNewswire

Apr. 22, 2026

Oxford Square Capital Corp. Schedules First Quarter 2026 Earnings Release and Conference Call for April 29, 2026

Indeterminate GlobeNewswire

Apr. 22, 2026

Hammond Power Solutions Announces First Quarter 2026 Financial Results Conference Call and Webcast Notification

Indeterminate GlobeNewswire

Apr. 22, 2026

Kneat to Announce 2026 First-Quarter Financial Results May 13, 2026

Indeterminate GlobeNewswire

Apr. 22, 2026

DELPHX ANNOUNCES NON-BROKERED PRIVATE PLACEMENT

Indeterminate GlobeNewswire

Apr. 22, 2026

George Medicines: New England Journal of Medicine publishes global stroke outcomes trial that demonstrated reduction of risk for recurrent stroke by almost 40% with GMRx2 in patients with previous intracerebral hemorrhage

Indeterminate GlobeNewswire

Apr. 22, 2026

Trident Resources Closes Option Agreement to Acquire Strategic Claims adjoining the Contact Lake Gold Project from North-Sask. Ventures Ltd. within the La Ronge Gold Belt

Indeterminate GlobeNewswire